Adrivanio Baranoski

Adrivanio Baranoski

Auto-generated profile, based on publicly available information

Adrivanio Baranoski

Department of General Biology, Center of Biological Sciences, Londrina State University - UEL, Rodovia Celso Garcia Cid, Pr 445 Km 380, Londrina, Paraná, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAna Luiza Sereia
Ana Luiza Sereia
MOMarcelo Tempesta de Oliveira
Marcelo Tempesta de Oliveira
ABAdrivanio Baranoski
Adrivanio Baranoski
LMLeila Larisa Medeiros Marques
Leila Larisa Medeiros Marques
FRFabianne Martins Ribeiro
Fabianne Martins Ribeiro
JMJoão Carlos Palazzo de Mello
João Carlos Palazzo de Mello
Alzheimer’s disease (AD) is the most common form of dementia and has no cure. Therapeutic strategies focusing on the reduction of oxidative stress, modulation of amyloid-beta (Aβ) toxicity and inhibition of tau protein hyperphosphorylation are warranted to avoid the development and progression of AD. The aim of this study was to screen the crude extracts (CEs) and ethyl-acetate fractions (EAFs) of Guazuma ulmifolia, Limonium brasiliense, Paullinia cupana, Poincianella pluviosa, Stryphnodendron adstringens and Trichilia catigua using preliminary in vitro bioassays (acetylcholinesterase inhibition, antioxidant activity and total polyphenol content) to select extracts/fractions and assess their protective effects against Aβ25–35 toxicity in SH-SY5Y cells. The effect of the EAF of S. adstringens on mitochondrial membrane potential, lipid peroxidation, superoxide production and mRNA expression of 10 genes related to AD was also evaluated and the electropherogram fingerprints of EAFs were established by capillary electrophoresis. Chemometric tools were used to correlate the in vitro activities of the samples with their potential to be evaluated against AD and to divide extracts/fractions into four clusters. Pretreatment with the EAFs grouped in cluster 1 (S. adstringens, P. pluviosa and L. brasiliense) protected SH-SY5Y cells from Aβ25-35-induced toxicity. The EAF of S. adstringens at 15.62 μg/mL was able completely to inhibit the mitochondrial depolarization (69%), superoxide production (49%) and Aβ25-35-induced lipid peroxidation (35%). With respect to mRNA expression, the EAF of S. adstringens also prevented the MAPT mRNA overexpression (expression ratio of 2.387x) induced by Aβ25–35, which may be related to tau protein hyperphosphorylation. This is the first time that the neuroprotective effects of these fractions have been demonstrated and that the electropherogram fingerprints for the EAFs of G. ulmifolia, L. brasiliense, P. cupana, P. pluviosa and S. adstringens have been established. The study expands knowledge of the in vitro protective effects and quality control of the evaluated fractions.

27 June 2017 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
BBBruna Isabela Biazi
Bruna Isabela Biazi
TZThalita Alves Zanetti
Thalita Alves Zanetti
ABAdrivanio Baranoski
Adrivanio Baranoski
ACAmanda Cristina Corveloni
Amanda Cristina Corveloni
MMMário Sérgio Mantovani
Mário Sérgio Mantovani

22 November 2018 in Drug Metabolism Letters
Verified
Journal Article
Open access
PDF file
SLSandra Regina Lepri
Sandra Regina Lepri
DSDaniele Sartori
Daniele Sartori
SSSimone Cristine Semprebon
Simone Cristine Semprebon
ABAdrivanio Baranoski
Adrivanio Baranoski
GCGiuliana Castello Coatti
Giuliana Castello Coatti
MMMario Sergio Mantovani
Mario Sergio Mantovani
• Background: Genistein (5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is the most abundant isoflavone in soybean, which has been associated with a lower risk of development of cancer and cardiovascular diseases. Of particular interest regarding cancer preventive properties of flavonoids is their interaction with cytochrome P450 enzymes (CYPs). However, contradictory data report the effect of genistein on expression of СYPs enzymes. • Objective: The aim of this study was to investigate the effects of genistein on cytochrome P450 (CYP) gene expression levels in human hepatocellular carcinoma (HepG2/C3A) and colon adenocarcinoma (HT29) cells. • Method: Real-time RT–PCR was used to examine the expression of genes families involved in xenobiotic metabolism, such as CYP1 (CYP1A1, CYP1B1), CYP2 (CYP2E1, CYP2D6), CYP3 (CYP3A4); and of a family involved in the catabolism of the all-trans-retinoic acid (ATRA), CYP26 (CYP26A1, CYP26B1). • Results: RT-qPCR data analysis showed that after 12 h of exposure of HepG2/C3A cells to genistein (5 and 50 µM) there was an upregulation of CYP1A1 and CYP1B1 and downregulation of CYP2D6, CYP26A1 and CYP26B1 mRNA levels. There was no change in the mRNA levels of CYP P450 genes in HT29 cells. • Conclusion: Our results suggest that treatment with genistein in non-toxic concentrations may impact the expression level of CYPs involved in the biotransformation of xenobiotics and drug metabolizing enzymes. Moreover, the downregulation of ATRA metabolism-related genes opens a new research path for the study of genistein as retinoic acid metabolism blocking agent for treating cancer and other pathologies.

1 April 2020 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
GCGiovanna Vaz Crippa
Giovanna Vaz Crippa
TZThalita Alves Zanetti
Thalita Alves Zanetti
BBBruna Isabela Biazi
Bruna Isabela Biazi
ABAdrivânio Baranoski
Adrivânio Baranoski
LMLilian Areal Marques
Lilian Areal Marques
MMMário Sérgio Mantovani
Mário Sérgio Mantovani


1 December 2018 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
MXMuriel Almeida Xavier
Muriel Almeida Xavier
MOMarcelo Tempesta de Oliveira
Marcelo Tempesta de Oliveira
ABAdrivanio Baranoski
Adrivanio Baranoski
MMMário Sérgio Mantovani
Mário Sérgio Mantovani
There is a lack of consensus on whether the role of folate in cancer cells is protective or harmful. The use of folates in combination with cancer-targeting therapeutic regimens requires detailed information to ensure their safe and proper use. Therefore, we evaluated the effects of folic acid (FA) in combination with the chemotherapeutic compounds doxorubicin (DXR), camptothecin (CPT) and methyl methanesulfonate (MMS) on the growth of MCF-7 cells. The data generated from the RTCA assays demonstrated that FA did not affect proliferation in MCF-7 cells treated with DXR and CPT; however, FA reduced the efficacy of MMS treatment. RTCA data also confirmed that DXR and CPT exert their cytotoxic effects in a time-dependent manner and that CPT induced a significantly greater decrease in MCF-7 cell proliferation compared with DXR. The MTT assay failed to detect a reduction in cell proliferation in cells treated with MMS. We quantified the mRNA expression levels of genes associated with cellular stress response, cell cycle and apoptosis pathways using RT-qPCR. The addition of FA to DXR or CPT promoted a similar shift in the gene expression profile of MCF-7 cells compared with cells treated with DXR or CPT without FA; however, this shift did not alter the bioactivity of these drugs. Rather, it indicated that these drugs promoted cell death by alternative mechanisms. In contrast, the addition of FA to MMS reduced the efficacy of the drug without changing the gene expression profile. None of the genes encoding folate receptors that were analyzed were differentially expressed in cells treated with or without FA. In conclusion, supplementation with 450 mu M FA was not cytotoxic to MCF-7 cells. However, the addition of FA to anti-cancer drugs must be performed cautiously as the properties of FA might lead to a reduction in drug efficacy. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.